These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25278732)

  • 21. Systematic review research on needle/syringe programs and opiate substitution programs in low- and middle-income countries.
    Jarlais DD
    J Food Drug Anal; 2013 Dec; 21(4):S59-S61. PubMed ID: 25267887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia.
    Baker LS; Smith W; Gulley T; Tomann MM
    J Community Health; 2020 Apr; 45(2):239-244. PubMed ID: 31502098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal analysis of change in individual-level needle and syringe coverage amongst a cohort of people who inject drugs in Melbourne, Australia.
    O'Keefe D; Scott N; Aitken C; Dietze P
    Drug Alcohol Depend; 2017 Jul; 176():7-13. PubMed ID: 28463684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-design of harm reduction materials for people who inject drugs to implement research findings.
    Hussey D; Trinder-Widdess Z; Dee C; Bagnall D; Bojangles T; Kesten JM
    Harm Reduct J; 2019 Jun; 16(1):36. PubMed ID: 31174536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia Region.
    Sharma M; Oppenheimer E; Saidel T; Loo V; Garg R
    AIDS; 2009 Jul; 23(11):1405-13. PubMed ID: 19579290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
    O'Keefe D; Aitken C; Scott N; Dietze P
    Drug Alcohol Depend; 2018 Oct; 191():259-265. PubMed ID: 30153607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives.
    Marshall Z; Dechman MK; Minichiello A; Alcock L; Harris GE
    Drug Alcohol Depend; 2015 Jun; 151():1-14. PubMed ID: 25891234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015-2016: A multi-method estimation study.
    Thanki D; Mravčík V; Běláčková V; Mačiulytė D; Zábranský T; Širvinskienė A; Subata E; Lorenzo-Ortega R
    J Subst Abuse Treat; 2021 Mar; 122():108229. PubMed ID: 33509418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of harm reduction in preventing HIV among injecting drug users.
    Wodak A; Maher L
    N S W Public Health Bull; 2010; 21(3-4):69-73. PubMed ID: 20513304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coverage of harm reduction services and HIV infection: a multilevel analysis of five Chinese cities.
    Wu Q; Kamphuis C; Duo L; Luo J; Chen Y; Richardus JH
    Harm Reduct J; 2017 Feb; 14(1):10. PubMed ID: 28193236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in Injection Risk Behaviors among People Who Inject Drugs and the Impact of Harm Reduction Programs in Ukraine, 2007-2013.
    Makarenko I; Ompad DC; Sazonova Y; Saliuk T; DeHovitz J; Gensburg L
    J Urban Health; 2017 Feb; 94(1):104-114. PubMed ID: 28097615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis.
    Tran LT; Peacock A; Colledge S; Memedovic S; Grebely J; Leung J; Larney S; Trickey A; Stone J; Vickerman P; Hickman M; Degenhardt L
    Int J Drug Policy; 2020 Oct; 84():102866. PubMed ID: 32712484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
    Ekhtiari H; Noroozi A; Farhoudian A; Radfar SR; Hajebi A; Sefatian S; Zare-Bidoky M; Razaghi EM; Mokri A; Rahimi-Movaghar A; Rawson R
    Addiction; 2020 Jul; 115(7):1395-1403. PubMed ID: 31737965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.
    Thakarar K; Nenninger K; Agmas W
    Infect Dis Clin North Am; 2020 Sep; 34(3):605-620. PubMed ID: 32782104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia.
    Mukherjee TI; Pillai V; Ali SH; Altice FL; Kamarulzaman A; Wickersham JA
    Int J Drug Policy; 2017 Sep; 47():144-152. PubMed ID: 28652072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harm reduction history, response, and current trends in Asia.
    Thomson N
    J Food Drug Anal; 2013 Dec; 21(4):S113-S116. PubMed ID: 25264414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
    Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
    Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis.
    Rahimi J; Gholami J; Amin-Esmaeili M; Fotouhi A; Rafiemanesh H; Shadloo B; Rahimi-Movaghar A
    Addiction; 2020 Apr; 115(4):605-622. PubMed ID: 31631425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.